ArticleCancer letters2022

Novel potent azetidine-based compounds irreversibly inhibit Stat3 activation and induce antitumor response against human breast tumor growth in vivo.

Peibin Yue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.